Literature DB >> 25065277

The association between premature coronary artery disease and level of testosterone in young adult males.

Abdulhakim Alkamel1, Akbar Shafiee1, Arash Jalali1, Mohammadali Boroumand1, Younes Nozari1.   

Abstract

OBJECTIVE: Low testosterone levels in men have been associated with an increased risk of cardiovascular disease. We aimed to identify the association between serum testosterone level and premature coronary artery disease (CAD) and its predictors in young adult males.
METHODS: In this cross sectional study, consecutive male candidates for coronary angiography with unstable angina, no previous CAD and age ≤ 45 years were included. Serum levels of free (FT) and total testosterone (TT) as well as demographic and cardiovascular characteristics were compared between the CAD-positive and normal coronary subjects. The cutoff point for low TT was 2.5 ng/L. Additionally, the relationships between all the variables and the number of affected vessels and FT and TT and predictors of CAD were assessed.
RESULTS: In this study, 191 patients with premature CAD were compared with 94 normal coronary subjects. Patients in the CAD group were significantly older (41.59 ± 3.79 versus 39.27 ± 4.97 years; P-value < 0.01), and had higher rates of diabetes mellitus (P-value = 0.04) and dyslipidemia (P-value = 0.01). Serum levels of FT and TT were significantly lower in the CAD group than the normal coronary subjects (P-value < 0.01 for both). The rate of subjects with low TT increased by the number of the affected vessels (p-value for trend <0.01) and there was a significant correlation between the Gensini score and FT and TT (r = -0.37, P-value < 0.01 and r = -0.34, P-value < 0.01, respectively). After adjustment for confounders, the association between low TT and CAD remained significant (Odds ratio = 4.30, 95% confidence interval: 1.99-9.32; P-value ≤ 0.001)
CONCLUSION: Low levels of testosterone were associated with premature CAD and its severity in young adults.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25065277     DOI: 014178/AIM.005

Source DB:  PubMed          Journal:  Arch Iran Med        ISSN: 1029-2977            Impact factor:   1.354


  7 in total

1.  Can Serum Testosterone Be Used as a Marker of Overall Health?

Authors:  Michael A Mederos; Aaron M Bernie; Jason M Scovell; Ranjith Ramasamy
Journal:  Rev Urol       Date:  2015

2.  Testosterone as a marker of coronary artery disease severity in middle aged males.

Authors:  Kunal Gururani; John Jose; Paul V George
Journal:  Indian Heart J       Date:  2016-08-08

3.  Frequency of Hypogonadism in Type 2 Diabetes Mellitus Patients with and without Coronary Artery Disease.

Authors:  Muhammad T Raza; Sabira Sharif; Zohaib Ahmad Khan; Sadaf Naz; Samsam Mushtaq; Amina Umer
Journal:  Cureus       Date:  2019-12-29

4.  Testosterone and dihydrotestosterone reduce platelet activation and reactivity in older men and women.

Authors:  Kamil Karolczak; Lucyna Konieczna; Tomasz Kostka; Piotr J Witas; Bartlomiej Soltysik; Tomasz Baczek; Cezary Watala
Journal:  Aging (Albany NY)       Date:  2018-05-02       Impact factor: 5.682

5.  Predictors of major adverse cardiac events following elective stenting of large coronary arteries.

Authors:  Hassan Aghajani; Abdolhakim Alkamel; Akbar Shafiee; Arash Jalali; Younes Nozari; Hamidreza Pourhosseini; Seyed Ebrahim Kassaian; Mojtaba Salarifar; Alimohammad Hajizeinali; Alireza Amirzadegan; Mohammad Alidoosti; Farzad Masoudkabir; Ebrahim Nematipour
Journal:  Indian Heart J       Date:  2017-06-19

6.  Low-density lipoprotein receptor gene mutation at Exon 2 and 4 in premature coronary artery disease in our population.

Authors:  Saqibah Rehman; Tariq Mahmood Ahmad; Asma Hayat; Sufyan Tahir
Journal:  Pak J Med Sci       Date:  2019 Jul-Aug       Impact factor: 1.088

Review 7.  Sex differences in acute cardiovascular care: a review and needs assessment.

Authors:  Saraschandra Vallabhajosyula; Dhiran Verghese; Viral K Desai; Pranathi R Sundaragiri; Virginia M Miller
Journal:  Cardiovasc Res       Date:  2022-02-21       Impact factor: 10.787

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.